Trials / Completed
CompletedNCT03760640
A Study of LY900014 in a Medtronic Pump
Evaluation of LY900014 in a Medtronic Pump
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the study drug LY900014 to insulin lispro (Humalog) when both are delivered by the Medtronic MiniMed 670G System in adults with type 1 diabetes (T1D). The study will consist of two treatment periods of 4 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY900014 | Administered SC |
| DRUG | Insulin Lispro | Administered SC |
Timeline
- Start date
- 2019-02-18
- Primary completion
- 2019-10-07
- Completion
- 2019-10-07
- First posted
- 2018-11-30
- Last updated
- 2020-10-29
- Results posted
- 2020-10-29
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03760640. Inclusion in this directory is not an endorsement.